CD163 and neuroblastoma: Chromosome 11q deletion or MYCN amplification in neuroblastomas exhibit higher numbers of M2-polarized (CD163+) macrophages and an activated Th2-lymphocytes/M2-macrophage axis compared to neuroblastoma lacking these mutations [72, 73, 85].